Clinical Trials
7 trialsNCT03077685 2024-06-24
Trial of NanoPacĀ® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
NanOlogy, LLC
Phase 2 Completed
NCT03717298 2023-03-28
Evaluation of Ocoxin-ViusidĀ® in Advanced Pancreatic Adenocarcinoma
Catalysis SL
Phase 2 Completed
NCT03410914 2021-11-03
PATCH-DP
Sunnybrook Health Sciences Centre
Phase 2 Completed
NCT03188991 2021-06-14
Intracystic Injection of NanoPacĀ® in Subjects With Mucinous Cystic Pancreatic Neoplasms
NanOlogy, LLC
Phase 2 Completed
NCT01088815 2019-04-26
Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT01608711 2017-05-16
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Astellas Pharma Inc
Phase 2 Completed
NCT00902291 2015-09-14
A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
Astellas Pharma Inc
Phase 2 Completed